drugset / Trial / NCT00441012
Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)
RandomizedParallel-groupDouble-blindPrevention
Summary
To determine if there is an improvement in the immune response to HBsAg (hepatitis B virus) in healthy infants using a modified process in a combination Haemophilus Influenzae, type b/Hepatitis B vaccine and a currently licensed Haemophilus Influenzae, type b/Hepatitis B vaccine
Timeline
- Start
- 2006-12
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Comvax | Vaccine | 0.5 ml | — |
| Subject | Modified Process Vaccine | Vaccine | 0.5 ml | — |